MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mindset Pharma Inc (OP:MSSTF)

N/A UNCHANGED
Last Price Updated: 3:55 PM EDT, Oct 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.5381
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic ↗
Clinical-stage biopharma company Reunion Neuroscience has received the FDA’s clearance on its Investigational New Drug (IND) application to begin a Phase 2 study of RE104, a novel serotonergic... 
Via Benzinga
News headline image
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More ↗
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety 
Via Benzinga

Performance

More News

Read More
News headline image
Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions ↗
Via Benzinga
News headline image
Terran Biosciences Steps Into 4-OH-DiPT Prodrug Arena With New Patent Application ↗
Via Benzinga
News headline image
Reunion Neuroscience On The Brink Of Going Private With Final Court Approval ↗
Via Benzinga
News headline image
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More ↗
Via Benzinga
News headline image
Reunion Neuroscience's Q4 And Full Year 2023 Financial Results, To Close Take-Private Deal In Q3 ↗
Via Benzinga
News headline image
UK Greenlights Phase 2 Clinical Trial On Mindset Pharma's Psilocin Drug For Major Depression ↗
Via Benzinga
News headline image
Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More ↗
Via Benzinga
News headline image
This Firm Bets On Non-Hallucinogenic Psychedelics, Files Claims For International IP Protection ↗
Via Benzinga
News headline image
New Clinical MDMA And Psilocybin Batches Head To Flourishing Psychedelics Market ↗
Via Benzinga
News headline image
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More ↗
Via Benzinga
News headline image
Two Major Psychedelics Companies Take Novel Chemical Entity Patent Battle To Federal Court ↗
Via Benzinga
News headline image
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More ↗
Via Benzinga
News headline image
Australia Receives First Batch Of Clinical-Grade Psilocybin From Mindset Pharma And PharmAla ↗
Via Benzinga
News headline image
Silo Pharma, Mindset Pharma, Terran Biosciences Receive Psychedelic Treatments Patents, IP Portfolios Expanded ↗
Via Benzinga
News headline image
Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More ↗
Via Benzinga
News headline image
Search Is On For Psychedelic Patents & FDA Designations, 3 Companies Share News ↗
Via Benzinga
News headline image
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More ↗
Via Benzinga
News headline image
These Two Psychedelics Companies Team Up In An Exclusive Sales Deal, Here Are The Details ↗
Via Benzinga
News headline image
Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement
From PharmAla Biotech
Via GlobeNewswire
News headline image
EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo, Market Subverticals & Informal Guidance ↗
Via Benzinga
News headline image
European Psychedelics Research Group Nabs $2M In Seed Funding As Clinical Research Picks Up Speed ↗
Via Benzinga
News headline image
Psyched: CA's Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More ↗
Via Benzinga
News headline image
Next-Generation Psychedelics Shows Promise With Upcoming Clinical Trials ↗
Via Benzinga

Frequently Asked Questions

Is Mindset Pharma Inc publicly traded?
Yes, Mindset Pharma Inc is publicly traded.
What exchange does Mindset Pharma Inc trade on?
Mindset Pharma Inc trades on the OTC Traded
What is the ticker symbol for Mindset Pharma Inc?
The ticker symbol for Mindset Pharma Inc is MSSTF on the OTC Traded
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story